{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-201313","form_type":"8-K","ticker":"SLNO","cik":"0001484565","company_name":"SOLENO THERAPEUTICS INC","filed_at":"2024-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.210522+00:00","generated_at":"2026-05-31T08:59:52.691881+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Soleno Therapeutics board changes: Chairman Mario resigns for health; Dawn Bir appointed as director","bullets":["Chairman Ernest Mario resigns effective August 15, 2024 for health reasons; no disagreement with company.","Dawn Carter Bir appointed to board effective August 15, 2024; receives 13,000 RSUs vesting over 3 years.","Matthew Pauls named Lead Independent Director; Andrew Sinclair chairs Compensation Committee.","Bir brings over 30 years biotech experience, led commercial launches at Reata and Pharmacyclics."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-201313","json":"https://secwatch.observer/filing/0001193125-24-201313.json","markdown":"https://secwatch.observer/filing/0001193125-24-201313.md","text":"https://secwatch.observer/filing/0001193125-24-201313.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484565/000119312524201313/0001193125-24-201313-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484565/000119312524201313/d856535d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:59:52.691881+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"abefc172b4","claim":"Dawn C. Bir was appointed as Director at SOLENO THERAPEUTICS INC.","evidence_excerpt":"On August 13, 2024, the Board appointed Dawn C. Bir to the Board effective upon Dr. Mario’s retirement on August 15, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484565/000119312524201313/0001193125-24-201313-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c0934b1587","claim":"Ernest Mario resigned as Chairman of the Board at SOLENO THERAPEUTICS INC.","evidence_excerpt":"On August 9, 2024, Dr. Ernest Mario, the Chairman of the Board of Directors (the “Board”) of Soleno Therapeutics, Inc. (the “Company”), notified the Company that he intended to resign from the Board for health reasons effective as of August 15, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484565/000119312524201313/0001193125-24-201313-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chairman of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}